World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
81
Citations
19159
World Ranking
1589
National Ranking
135

Medicine

D-Index
81
Citations
19187
World Ranking
16816
National Ranking
1529

Mark Peakman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mark Peakman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 359 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mark Peakman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Peakman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mark Peakman is affiliated with King's College London in the United Kingdom. Their research centers primarily on medicine, with significant contributions to biochemistry, genetics, molecular biology, immunology, and microbiology. Key subfields in their work include genetics, immunology, endocrinology, diabetes and metabolism, surgery, and physiology.

The scientist has published extensively on topics related to diabetes and associated disorders, with particular emphasis on pancreatic function and diabetes, diabetes management and research, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy and immune responses, as well as asthma and respiratory diseases.

Peakman's work appears frequently in several academic journals. Venues with multiple publications include:

  • Diabetologia
  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Diabetes/Metabolism Research and Reviews
  • EBioMedicine

Among their recent research papers are:

  • Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes, 2020, Nature Immunology
  • Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection System, 2020, Frontiers in Immunology
  • INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetes, 2022, Trials
  • Synchronization of the Normal Human Peripheral Immune System: A Comprehensive Circadian Systems Immunology Analysis, 2020, Scientific Reports
  • GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells, 2020, Diabetologia

In collaborative research, Peakman frequently coauthors with several other scientists, including:

  • Timothy Tree
  • Mikael Knip
  • Chantal Mathieu
  • Lut Overbergh
  • Anke M. Schulte

Best Publications

  • Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

    Shelley Lindley;Colin M. Dayan;Amanda Bishop;Bart O. Roep

  • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

    Sefina Arif;Timothy I. Tree;Thomas P. Astill;Jennifer M. Tremble

  • A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides

    Linda Wooldridge;Julia Ekeruche-Makinde;Hugo A. van den Berg;Anna Skowera;Anna Skowera

  • CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

    Ania Skowera;Richard J. Ellis;Ruben Varela-Calviño;Sefina Arif

  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

    Manuela Battaglia;Simi Ahmed;Mark S. Anderson;Mark A. Atkinson

  • Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

    Chung-Ching Chu;Niwa Ali;Panagiotis Karagiannis;Paola Di Meglio

  • Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

    T. P. Di Lorenzo;M. Peakman;B. O. Roep

  • Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM

    M. J. Hussain;M. Peakman;H. Gallati;S. S. S. Lo

  • Antigen Targets of Type 1 Diabetes Autoimmunity

    Bart O Roep;Mark Peakman

  • Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death

    Sefina Arif;Fabrice Moore;Katherine Marks;Thomas Bouckenooghe

  • Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes

    Sefina Arif;Pia Leete;Vy Thuy Nguyen;Katherine Marks

  • Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function

    Garima Garg;Jennifer R Tyler;Jennie H M Yang;Antony J Cutler

  • Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.

    Anna Marta Bulek;David Cole;Ania Skowera;Ania Skowera;Garry Michael Dolton

  • Simultaneous Detection of Circulating Autoreactive CD8 + T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers

    Jurjen H. Velthuis;Wendy W. Unger;Joana R.F. Abreu;Gaby Duinkerken;Gaby Duinkerken

  • Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes

    J. M. Lawson;J. Tremble;Colin Mark Dayan;H. Beyan

  • Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?

    Caroline M. Hull;Mark Peakman;Mark Peakman;Timothy I. M. Tree;Timothy I. M. Tree

  • Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes

    Federica Vecchio;Nicola Lo Buono;Angela Stabilini;Laura Nigi

  • Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes

    Mohammad Alhadj Ali;Yuk-Fun Liu;Yuk-Fun Liu;Sefina Arif;Danijela Tatovic

  • Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

    Tihamer Orban;Brian Bundy;Dorothy J. Becker;Linda A. DiMeglio

  • Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes

    Menno van Lummel;Gaby Duinkerken;Peter A. van Veelen;Arnoud de Ru

  • Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity

    David Cole;Anna Marta Bulek;Garry Michael Dolton;Andrea J. Schauenberg

  • Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1

    Sefina Arif;Pia Leete;Vy Nguyen;Katherine Marks

Frequent Co-Authors

Diego Vergani
Diego Vergani King's College London
Bart O. Roep
Bart O. Roep Leiden University Medical Center
Timothy I. M. Tree
Timothy I. M. Tree King's College London
Andrew K. Sewell
Andrew K. Sewell Cardiff University
John J. Miles
John J. Miles James Cook University
Adrian Hayday
Adrian Hayday King's College London
David Price
David Price University of Aberdeen
David B. Dunger
David B. Dunger University of Cambridge
John A. Todd
John A. Todd University of Oxford
Simon Wessely
Simon Wessely King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, various online degree options can help build a strong foundation in healthcare and research. Many aspiring professionals start with programs like easiest absn program to get into, which provides an accelerated pathway for non-nurses to earn a Bachelor of Science in Nursing quickly. This can be a great stepping stone toward advanced immunology-related roles.

Another popular route is enrolling in online rn programs for non nurses in florida. These programs are tailored for individuals transitioning into nursing from different fields, offering flexibility and recognized credentials.

For those aiming to specialize, acnp programs offer advanced clinical training to become Acute Care Nurse Practitioners, supporting patients with complex immunological conditions in hospital settings.

Lastly, students seeking a condensed pathway can consider an accelerated np program, designed to quickly prepare registered nurses for nurse practitioner roles. Together, these degree pathways provide versatile options for building a career in immunology and related healthcare fields.

Best Scientists Citing Mark Peakman

Trending Scientists

Recently Published Articles